-
- 市川 誠一
- 神奈川県立衛生短期大学公衆衛生学研究室
-
- 木村 哲
- 東京大学大学院医学系研究科・感染制御学・感染症内科学
-
- 大屋 日登美
- 神奈川県立衛生短期大学公衆衛生学研究室
-
- 木村 博和
- 横浜市立大学医学部公衆衛生学教室
-
- 岡 慎一
- 国立国際医療センター
-
- 伊藤 章
- 横浜市立大学医学部臨床検査部
-
- 増田 剛太
- 東京都立駒込病院感染症科
-
- 花房 秀次
- 荻窪病院血液科
-
- 相楽 裕子
- 横浜市立市民病院感染症科
-
- 橋本 修二
- 東京大学大学院医学系研究科健康科学・看護学専攻
-
- 鎌倉 光宏
- 慶應義塾大学医学部衛生学公衆衛生学教室・感染症クリニック
-
- 中村 好一
- 自治医科大学公衆衛生学教室
-
- 木原 正博
- 神奈川県立がんセンター臨床研究所研究第三科
書誌事項
- タイトル別名
-
- A Study on the Medical Care Cost for People with HIV/AIDS in Japan
- HIV AIDS イリョウヒ ニ カンスル ケンキュウ AZT ddI ノ シメル ヒヨウ ワリアイ
- AZT, ddIの占める費用割合
この論文をさがす
抄録
Objective: In this study, we categorized patients with HIV (PWH) and AIDS (PWA) according to the CD4 cell count, and separately analyzed the costs of outpatient and inpatient care for the hemophiliac and non-hemophiliac patients in each category.<BR>Materials & Methods: HIV infection was classified into 4 stages reflecting severity of disease. The stages were AC-1 (n=28), CD4 cell count ≥500; AC-2 (n=45), CD4 count 200-500; AC-3 (n=34), CD4 count less than 200; and AIDS patients (n=46). The costs of outpatient and inpatient care for PWH and PWA were investigated on the basis of receipts for monthly statements of insurance payments. The costs of medication were calculated item by item for each patient, and the mean cost of medical care per day was calculated for the 4 disease stage groups by dividing the costs by the actual number of days of outpatient or inpatient care. In the patients receiving anti-HIV drugs, we calculated the costs of AZT and ddI, and determined the percentage of the total cost of medical care occupied by anti-HIV drugs.<BR>Results: The monthly cost of medical care for the non-hemophiliac patients receiving anti-HIV drugs was 2.5 times and 3.5 times higher in the AC-2 and AC-3 groups, respectively, than that in the AC-1 group of patients not receiving anti-HIV drugs. The cost of anti-HIV drugs accounted for more than 60% of the total cost. A similar tendency was also observed in the hemophiliac patients, and anti-HIV drugs accounted for 40-60% of the cos of medical care excluding the home-care costs of coagulation factor products . The life-time cost for HIV/AIDS treatment with anti-HIV drugs was estimated to be 13, 440, 000 yen.<BR>Conclusion: The cost of outpatient care increased as the disease progressed; especially, in terms of the use of anti-HIV drugs.
収録刊行物
-
- 日本エイズ学会誌
-
日本エイズ学会誌 2 (1), 22-29, 2000
日本エイズ学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679445213184
-
- NII論文ID
- 130003857848
- 10020441623
-
- NII書誌ID
- AA11379941
-
- ISSN
- 18842763
- 13449478
-
- NDL書誌ID
- 5314386
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可